Volker Hirsch
Trained as a lawyer, Volker spent over two decades in technology businesses in the UK, US, Germany and beyond, where he drove corporate strategy, growth and expansion. After 20 year career as an entrepreneur and technology investor, Volker joined Medicines Discovery Catapult (MDC) as Chief Commercial Officer in August 2022. Volker joined MDC from renowned […]
Robert Sherville-Payne
With a professional legal and compliance background and over 25 years of commercial experience, Robert brings significant expertise as a solicitor to his role as General Counsel and Company Secretary at Medicines Discovery Catapult. Having trained and worked at law firm Hogan Lovells in London, Robert spent 14 years at AstraZeneca in a range of […]
Sinéad McCormack
Sinéad is a qualified accountant with 23 years of experience, holding senior positions in financial services and higher education with organisations including Barclays, Bank of England and the University of Manchester. Having started her career with Aspect Capital, AIG and Barclays, Sinéad then joined the Bank of England as Senior Manager of Financial of Control […]
Clare Atherton
Clare brings a plethora of HR experience gained throughout her career in the rail, retail, FMCG, science and technology sectors to her role as Chief People Officer at Medicines Discovery Catapult (MDC). Having started her career within the Rail sector, Clare has held senior positions in private and public sector organisations – most recently with […]
Dr Nicola Heron
Nicola has over 24 years of life science experience, holding senior positions across the public and private sectors in organisations including AstraZeneca and the NHS. With a broad range of experience from research to commercialisation in pharmaceuticals, medical devices and diagnostics, Nicola brings a breadth of experience to her role as Chief Strategy Officer at […]
Professor Chris Molloy
Professor Chris Molloy has a 30-year international board and executive career across a unique range of life sciences R&D disciplines. His career began in preclinical research at Glaxo, where he was closely involved with the industrialisation of high throughput discovery. In 2004 he moved to Asia as COO of MerLion Pharmaceuticals, a Singaporean biotech that […]